list of glp-1 agonists Market Overview: and the Obesity Market | Blog List of current GLP-1 and
Description
Even though the risk was more than doubled, the overall risk of developing wet AMD was very low: only 93 patients taking GLP-1 medications developed wet AMD after three years among over 46,000 patients in the study
The neuroprotective effects of glucagon-like peptide 1 in Alzheimers and Parkinsons disease: An in-depth review
Weight regain is common and well-documented
[DOI] [PubMed] [Google Scholar] 120.Trujillo J
20 If DR is observed with GLP-1RA use, accelerated follow-up compared with typical monitoring should help rule out treatable retinopathy
